Uganda - anglų - National Drug Authority

aculife healthcare pvt ltd - multi-ingredient - parenteral ordinary infusion dry vials/bottles - multi-ingredient

Uganda - anglų - National Drug Authority

aculife healthcare pvt ltd - multi-ingredient - parenteral ordinary infusion vials/bottles - multi-ingredient

Uganda - anglų - National Drug Authority

medipharm sales limited - multi-ingredient - oral liquid ordinary syrups - multi-ingredient

Uganda - anglų - National Drug Authority

sk age exports - multi-ingredient - oral liquid ordinary syrups - multi-ingredient

Uganda - anglų - National Drug Authority

south egypt drug industries co. (sedico) - multi-ingredients - oral solid ordinary capsules - multi-ingredients

Uganda - anglų - National Drug Authority

eagle vet tech co., ltd - multi-vitamin - parenteral ordinary i m vials - multi-ingredient

Uganda - anglų - National Drug Authority

gittoes pharmaceuticals limited; gittoes pharmaceuticals limited - multivitamin - oral solid ordinary chewable tablets - multi-ingredient

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

rebel distributors corp - pramipexole dihydrochloride (unii: 3d867np06j) (pramipexole - unii:83619peu5t) - pramipexole dihydrochloride 0.500 mg - mirapex® (pramipexole dihydrochloride) tablets are indicated for the treatment of the signs and symptoms of idiopathic parkinson's disease. the effectiveness of mirapex tablets was demonstrated in randomized, controlled trials in patients with early parkinson's disease who were not receiving concomitant levodopa therapy as well as in patients with advanced disease on concomitant levodopa (see clinical studies ). mirapex tablets are indicated for the treatment of moderate-to-severe primary restless legs syndrome (rls). key diagnostic criteria for rls are: an urge to move the legs usually accompanied or caused by uncomfortable and unpleasant leg sensations; symptoms begin or worsen during periods of rest or inactivity such as lying or sitting; symptoms are partially or totally relieved by movement such as walking or stretching at least as long as the activity continues; and symptoms are worse or occur only in the evening or night. difficulty falling asleep may frequently be associated with symptoms of rls. mir

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

physicians total care, inc. - pramipexole dihydrochloride (unii: 3d867np06j) (pramipexole - unii:83619peu5t) - pramipexole dihydrochloride 0.500 mg - mirapex® (pramipexole dihydrochloride) tablets are indicated for the treatment of the signs and symptoms of idiopathic parkinson's disease. the effectiveness of mirapex tablets was demonstrated in randomized, controlled trials in patients with early parkinson's disease who were not receiving concomitant levodopa therapy as well as in patients with advanced disease on concomitant levodopa (see clinical studies ). mirapex tablets are indicated for the treatment of moderate-to-severe primary restless legs syndrome (rls). key diagnostic criteria for rls are: an urge to move the legs usually accompanied or caused by uncomfortable and unpleasant leg sensations; symptoms begin or worsen during periods of rest or inactivity such as lying or sitting; symptoms are partially or totally relieved by movement such as walking or stretching at least as long as the activity continues; and symptoms are worse or occur only in the evening or night. difficulty falling asleep may frequently be associated with symptoms of rls. mir

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

multimin north america, inc. - zinc oxide (unii: soi2loh54z) (zinc cation - unii:13s1s8sf37), manganese carbonate (unii: 9zv57512zm) (manganese cation (2+) - unii:h6ep7w5457), sodium selenite (unii: hiw548rq3w) (selenite ion - unii:kxo0259xj1), cupric carbonate (unii: 9aoa5f11gj) (cupric cation - unii:8cbv67279l) - zinc cation 60 mg in 1 ml